Clinical Trial Update: Efficiency Study of S-Tenatoprazole-Na to Treat Erosive or Ulcerative Esophagitis [Phase 2]

View source ↗

Summary

A Phase 2 study of S-Tenatoprazole-Na for erosive or ulcerative esophagitis has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Reflux Esophagitis

Drugs mentioned

• S-Tenatoprazole-Na (tenatoprazole sodium)

Snippet

Sponsor: STEBA France | Conditions: Esophagitis, Reflux | Phase 2 | Status: SUSPENDED